BR6681517D0 - Processo para a obtencao de novas 4,5,6,7-tetraidro-tiazolo-5,4-c piridinas - Google Patents
Processo para a obtencao de novas 4,5,6,7-tetraidro-tiazolo-5,4-c piridinasInfo
- Publication number
- BR6681517D0 BR6681517D0 BR181517/66A BR18151766A BR6681517D0 BR 6681517 D0 BR6681517 D0 BR 6681517D0 BR 181517/66 A BR181517/66 A BR 181517/66A BR 18151766 A BR18151766 A BR 18151766A BR 6681517 D0 BR6681517 D0 BR 6681517D0
- Authority
- BR
- Brazil
- Prior art keywords
- thiazolo
- pyridines
- tetrahydro
- obtaining new
- obtaining
- Prior art date
Links
- RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F9/00—Component parts of dredgers or soil-shifting machines, not restricted to one of the kinds covered by groups E02F3/00 - E02F7/00
- E02F9/20—Drives; Control devices
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Mining & Mineral Resources (AREA)
- Civil Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Structural Engineering (AREA)
- Molecular Biology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DET0029055 | 1965-07-23 | ||
| DET0032994 | 1967-01-16 | ||
| DET0032992 | 1967-01-16 | ||
| DET0032991 | 1967-01-16 | ||
| DET0032993 | 1967-01-16 | ||
| DET0032990 | 1967-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR6681517D0 true BR6681517D0 (pt) | 1973-12-27 |
Family
ID=27512321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR181517/66A BR6681517D0 (pt) | 1965-07-23 | 1966-07-22 | Processo para a obtencao de novas 4,5,6,7-tetraidro-tiazolo-5,4-c piridinas |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE684415A (enExample) |
| BR (1) | BR6681517D0 (enExample) |
| DE (1) | DE1620508A1 (enExample) |
| ES (9) | ES329299A1 (enExample) |
| FR (3) | FR6013M (enExample) |
| GB (1) | GB1140387A (enExample) |
| NL (2) | NL6610324A (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847264A (en) * | 1982-07-21 | 1989-07-11 | Rorer Pharmaceutical Corporation | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses |
| GB8333514D0 (en) * | 1983-12-16 | 1984-01-25 | Erba Farmitalia | Tetrahydrothiazolo(5 4-c)pyridine derivatives |
| DE3680929D1 (de) | 1985-02-06 | 1991-09-26 | Boehringer Ingelheim Kg | Verwendung des 2-amino-6-allyl-5,6,7,8-tetrahydro-4h-thiazolo(4,5-d)azepins zur herstellung eines zur behandlung der parkinsonschen erkrankung bzw. des parkinsonismus geeigneten arzneimittels. |
| GB2173187B (en) * | 1985-03-23 | 1988-05-18 | Erba Farmitalia | Condensed 2-substituted thiazole derivatives |
| US5060904A (en) * | 1987-05-01 | 1991-10-29 | David Hegarty | Multi-positionable support stand with movable center of gravity and article holding means |
| EP1037633B1 (en) * | 1997-12-11 | 2003-09-10 | Biochem Pharma Inc. | Antiviral compounds |
| SE0001899D0 (sv) | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
| EA200400707A1 (ru) | 2001-11-22 | 2004-10-28 | Биовитрум Аб | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 |
| AR041952A1 (es) | 2002-11-14 | 2005-06-01 | Novartis Ag | N-sulfonilaminotiazol |
| CL2004000553A1 (es) | 2003-03-20 | 2005-02-04 | Actelion Pharmaceuticals Ltd | Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende. |
| KR101215153B1 (ko) | 2003-11-12 | 2012-12-24 | 다이이찌 산쿄 가부시키가이샤 | 티아졸 유도체의 제조법 |
| US8541592B2 (en) | 2005-11-22 | 2013-09-24 | Amgen Inc. | Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| WO2010071822A1 (en) * | 2008-12-19 | 2010-06-24 | Schering Corporation | Piperidine and piperazine derivatives and methods of use thereof |
| CA2756989A1 (en) * | 2009-04-03 | 2010-10-07 | Douglas Burdi | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| US11071721B2 (en) | 2016-12-02 | 2021-07-27 | Genentech, Inc. | Bicyclic amide compounds and methods of use thereof |
| CN119613408A (zh) | 2017-07-14 | 2025-03-14 | 豪夫迈·罗氏有限公司 | 二环酮化合物及其使用方法 |
| MX2020003451A (es) | 2017-10-31 | 2020-08-03 | Hoffmann La Roche | Sulfonas y sulfoxidos biciclicos y metodos de uso de los mismos. |
| CN109134510A (zh) * | 2018-11-13 | 2019-01-04 | 井冈山大学 | 制备2-氨基-5-cbz-4,5,6,7-四氢噻唑并[5，4-c]吡啶的新方法 |
| CN113302193B (zh) | 2019-01-11 | 2026-05-29 | 豪夫迈·罗氏有限公司 | 双环吡咯并三唑酮化合物及其使用方法 |
-
1965
- 1965-07-23 DE DE19651620508 patent/DE1620508A1/de active Pending
-
1966
- 1966-07-15 GB GB31938/66A patent/GB1140387A/en not_active Expired
- 1966-07-20 ES ES329299A patent/ES329299A1/es not_active Expired
- 1966-07-20 BE BE684415D patent/BE684415A/xx unknown
- 1966-07-22 NL NL6610324A patent/NL6610324A/xx unknown
- 1966-07-22 FR FR70538A patent/FR6013M/fr not_active Expired
- 1966-07-22 FR FR70539A patent/FR1498465A/fr not_active Expired
- 1966-07-22 BR BR181517/66A patent/BR6681517D0/pt unknown
-
1968
- 1968-01-15 NL NL6800589A patent/NL6800589A/xx unknown
- 1968-01-15 ES ES349322A patent/ES349322A1/es not_active Expired
- 1968-01-15 ES ES349321A patent/ES349321A1/es not_active Expired
- 1968-01-15 ES ES349314A patent/ES349314A1/es not_active Expired
- 1968-01-15 ES ES349317A patent/ES349317A1/es not_active Expired
- 1968-01-15 ES ES349316A patent/ES349316A1/es not_active Expired
- 1968-01-15 ES ES349318A patent/ES349318A1/es not_active Expired
- 1968-01-15 ES ES349319A patent/ES349319A1/es not_active Expired
- 1968-01-15 ES ES349320A patent/ES349320A1/es not_active Expired
- 1968-01-16 FR FR136259A patent/FR94123E/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES349317A1 (es) | 1969-04-01 |
| ES349321A1 (es) | 1969-04-01 |
| NL6800589A (enExample) | 1968-07-17 |
| ES329299A1 (es) | 1968-02-16 |
| ES349322A1 (es) | 1969-04-01 |
| BE684415A (enExample) | 1967-01-20 |
| FR6013M (enExample) | 1968-05-06 |
| ES349316A1 (es) | 1969-04-01 |
| ES349320A1 (es) | 1969-04-01 |
| FR1498465A (fr) | 1967-10-20 |
| ES349314A1 (es) | 1969-04-01 |
| FR94123E (fr) | 1969-07-04 |
| ES349318A1 (es) | 1969-04-01 |
| NL6610324A (enExample) | 1967-01-24 |
| GB1140387A (en) | 1969-01-15 |
| DE1620508A1 (de) | 1969-09-18 |
| ES349319A1 (es) | 1969-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR6576150D0 (pt) | Processo para a preparacao de 4-aril-isoflavanoides | |
| BR6682746D0 (pt) | Processo para a preparacao de novos derivados de ciclopentanofenantreno | |
| BR6681446D0 (pt) | Processo para a preparacao de nucleosideos | |
| BR6684787D0 (pt) | Processo para a preparacao de difenil-alcoil-aminas substituidas | |
| BR6685453D0 (pt) | Processo para a obtencao de novos derivados da desglucohelebrina | |
| BR6676358D0 (pt) | Processo para a obtencao de novos derivados de picolilamina | |
| BR6911744D0 (pt) | Processo para a preparacao de novas 5,10-dihidro-11 h-dibenzeno (b,e) (1,4) diazepin-11-onas substituidas em posicao 5 | |
| BR6685240D0 (pt) | Processo para a obtencao de novos d-homoesteroides | |
| BR6683054D0 (pt) | Processo para a preparacao de diaminas | |
| BR6682693D0 (pt) | Processo para a preparacao de benzenossulfonilureias | |
| BR6679318D0 (pt) | Processo para a preparacao de benzenossulfo-nilsemicarbazidas | |
| BR6678776D0 (pt) | Processo para preparacao de imidazois | |
| BR6684443D0 (pt) | Processo para a preparacao de derivados de 1,4-benzodioxano | |
| BR6679086D0 (pt) | Processo para a producao de 3-substituido-5-(2-halogenoetil)-2-oxazolidinonas | |
| BR6680680D0 (pt) | Processo para a preparacao de oxaza-heterociclos | |
| BR6682775D0 (pt) | Processo para preparar novas 2-hidroxi-3-substituido propil 1,4-naftoquinonas | |
| BR6679324D0 (pt) | Processo para a obtencao de novas imidas ciclicas | |
| BR6677313D0 (pt) | Processo para a preparacao de insulina | |
| BR6682173D0 (pt) | Processo para a obtencao de novos derivados de 5-nitrofurila | |
| BR6681685D0 (pt) | Processo aperfeicoado para a obtencao de fenilacetonitrilas basicamente substituidas | |
| BR6682929D0 (pt) | Processo aperfeicoado para a producao de 7-cloro 13 diidro-1-metil-5-fenil-2h-1,4-benzodiazepin-2-ona | |
| BR6680379D0 (pt) | Processo de preparacao de novos derivados do dibenzocicloheptatrieno | |
| BR6679622D0 (pt) | Processo para a obtencao de derivados de 1-hidroxi-estradiol | |
| BR6683163D0 (pt) | Processo para a obtencao de 5-beta-h-6-ceto-14 alfa -delta 7-hidroxiesteroides | |
| BR6681609D0 (pt) | Processo para a preparacao de benzenossulfanil-ureias |